Nanologica Ab

Nanologica is a Swedish nanotechnology company, world-leading in the development of nanoporous silica particles for purification by chromatography. A proprietary production method enables the company to create supreme products by precisely controlling the shape, size, porosity, and surface properties of silica particles. Nanologica provides products of high-quality silica used in the purification of peptide drugs such as insulin and GLP-1 analogues. These products can contribute to lower costs and increase productivity for pharmaceutical manufacturers, which can increase the availability of cost-effective medicines and give more people around the world access to vital treatment for diabetes and obesity. Nanologica is headquartered in Södertälje and Nanologica's share (NICA) is listed on Nasdaq Stockholm Main Market. For further information, please visit